Guillain–Barré syndrome after an asymptomatic COVID‐19 Infection: a case report

• Marwa TOUMIA

• Fatma Zaouali

• Lamia Bouzgarrou

Background: Guillain–Barré syndrome (GBS) is an acute, immune-mediated generalized polyradiculoneuropathy often preceded by several infections. In most cases of GBS linked to SARS-CoV-2 worldwide, the infected individuals developed COVID-19 symptoms. This case report aims to present a case of a GBS post asymptomatic COVID-19 infection discovered in the emergency department of the regional hospital of Ksar Hellal.

Case Presentation: A 55-year-old man consulted the emergency department complaining of lumbar pain treated as a lumbar discal hernia. After 2 days, he developed acute weakness in the lower limbs. Neurological examination revealed a sensory-motor deficit in the lower limbs. The evolution was: absent deep tendon reflexes in the lower limbs, ascending flaccid symmetrical limb paralysis with tetraplegia, swallowing disorder, urinary incontinence, and central respiratory depression. A clinical diagnosis of GBS was made. The patient was transferred to the intensive care unit. He required invasive mechanical ventilation. Cerebrospinal fluid analysis revealed albumin cytologic dissociation. The serology was in favor of a recent COVID-19 infection. The patient was treated with intravenous immunoglobulin at 0.4 g/kg/day for 5 days. His clinical condition improved gradually. He was transitioned out of the intensive care unit after one month.

Conclusion: During the pandemic, all patients with suspected GBS should have SARS-CoV-2 tests to allow eventual rapid isolation. We expect an increase in the rate of GBS without an obvious cause, as long as one can have GBS after an asymptomatic COVID-19 infection. The doctor should be standing by to provide rapid, adequate assistance if required.

• PDF

Copyright (c) 2025 Tunisian Journal of Emergency Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

THE tjem allows authors to retain unrestricted copyright and full publishing rights of their articles.

All articles published in this journal are openly accessible and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This guarantees that anyone is free to:

• Share: Copy and redistribute the material in any medium or format.

• Adapt: Remix, transform, and build upon the material for any purpose, even commercially.

Under the following terms:

• Attribution: Users must give appropriate credit to the original author(s) and the journal, provide a link to the license, and indicate if changes were made.

By submitting a manuscript to tjem, authors grant the journal the right of first publication, while retaining full ownership of their intellectual property.